Cargando…
Spotlight on grazoprevir–elbasvir once-daily combination and its potential in the treatment of hepatitis C
Chronic hepatitis C virus (HCV) infection is a leading cause of health care utilization in the USA. Incidence of cirrhosis from HCV is expected to rise in the near future, further increasing this burden. There is a high medical need for effective, tolerable, safe, all-oral, short-duration therapy. T...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933565/ https://www.ncbi.nlm.nih.gov/pubmed/27418810 http://dx.doi.org/10.2147/DDDT.S90537 |